Geng Sheng Yang
Directeur/Membre du Conseil chez XinYu Pharmaceutical Co., Ltd.
Profil
Geng Sheng Yang is an Independent Director at XinYu Pharmaceutical Co., Ltd.
since 2015.
He completed his undergraduate degree from Zhejiang University of Technology in 1985.
Postes actifs de Geng Sheng Yang
| Sociétés | Poste | Début |
|---|---|---|
XinYu Pharmaceutical Co., Ltd.
 XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Directeur/Membre du Conseil | 01/09/2015 |
Formation de Geng Sheng Yang
| Zhejiang University of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
XinYu Pharmaceutical Co., Ltd.
XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
